MORGAN STANLEY - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 111 filers reported holding ACORDA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 33.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,000
+12.5%
13,754
-8.2%
0.00%
Q3 2020$8,000
-68.0%
14,982
-56.5%
0.00%
Q2 2020$25,000
-88.4%
34,417
-85.2%
0.00%
Q1 2020$215,000
-55.1%
231,816
-1.2%
0.00%
Q4 2019$479,000
+1.5%
234,739
+42.7%
0.00%
Q3 2019$472,000
-75.0%
164,551
-33.1%
0.00%
-100.0%
Q2 2019$1,887,000
+77.3%
245,926
+206.9%
0.00%
Q1 2019$1,064,000
-5.2%
80,122
+11.3%
0.00%
Q4 2018$1,122,000
-53.9%
71,980
-41.9%
0.00%
-100.0%
Q3 2018$2,436,000
-61.4%
123,995
-43.7%
0.00%
-50.0%
Q2 2018$6,319,000
+26.6%
220,175
+4.4%
0.00%
+100.0%
Q1 2018$4,991,000
-55.5%
210,992
-59.6%
0.00%
-66.7%
Q4 2017$11,212,000
+507.4%
522,697
+569.9%
0.00%
+200.0%
Q3 2017$1,846,000
-39.5%
78,030
-49.6%
0.00%0.0%
Q2 2017$3,052,000
-40.9%
154,948
-37.0%
0.00%0.0%
Q1 2017$5,166,000
-63.4%
245,970
-67.3%
0.00%
-50.0%
Q4 2016$14,126,000
+147.0%
751,270
+174.3%
0.00%0.0%
Q3 2016$5,720,000
-49.5%
273,871
-38.3%
0.00%
-50.0%
Q2 2016$11,316,000
-1.2%
443,680
+2.4%
0.00%0.0%
Q1 2016$11,459,000
+447.8%
433,237
+786.1%
0.00%
+300.0%
Q4 2015$2,092,000
+106.9%
48,894
+28.2%
0.00%
Q3 2015$1,011,000
+112.4%
38,135
+167.4%
0.00%
Q2 2015$476,000
-97.1%
14,261
-97.1%
0.00%
-100.0%
Q1 2015$16,290,000
+443.0%
489,506
+566.9%
0.01%
+500.0%
Q4 2014$3,000,000
-27.3%
73,402
-39.7%
0.00%
-50.0%
Q3 2014$4,126,000
-49.2%
121,748
-49.5%
0.00%
-33.3%
Q2 2014$8,130,000
+209.1%
241,180
+247.7%
0.00%
+200.0%
Q1 2014$2,630,000
-70.9%
69,364
-77.6%
0.00%
-75.0%
Q4 2013$9,046,000
+158.2%
309,808
+202.5%
0.00%
+100.0%
Q3 2013$3,504,000
+19.6%
102,423
+15.4%
0.00%
+100.0%
Q2 2013$2,929,00088,7730.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders